Susquehanna options strategists Alison Edwards notes bullish options activity in Gilead Sciences (NASDAQ: GILD), following the company's earnings announcement, as an opening investor bought ~10,000 Dec 70 Calls for $3.30 creating ~400,000 shares to buy.

Options Trader Talk

Gilead Sciences (GILD) PT Raised to $76 at BMO Capital Following 1QMay 3, 2017 9:17 AM Gilead Sciences (GILD): Bright Spots Among The Misses - StifelMay 3, 2017 8:21 AM Gilead Sciences (GILD): Quiet 1Q17 Earnings - BairdMay 3, 2017 8:13 AM Gilead Sciences (GILD) Declares $0.52 Quarterly Dividend; 3% YieldMay 2, 2017 4:03 PM Gilead Sciences (GILD) Misses Q1 EPS by 5c; Reiterates Full Year 2017 Guidance May 2, 2017 4:02 PM